Teachers Retirement System of The State of Kentucky lessened its holdings in shares of Agilent Technologies, Inc. (NYSE:A – Get Rating) by 4.2% in the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 21,429 shares of the medical research company’s stock after selling 932 shares during the quarter. Teachers Retirement System of The State of Kentucky’s holdings in Agilent Technologies were worth $2,836,000 as of its most recent filing with the Securities & Exchange Commission.
Other hedge funds and other institutional investors also recently made changes to their positions in the company. Riverview Trust Co bought a new position in shares of Agilent Technologies during the first quarter valued at approximately $33,000. Glassman Wealth Services raised its holdings in Agilent Technologies by 47.4% in the fourth quarter. Glassman Wealth Services now owns 230 shares of the medical research company’s stock worth $37,000 after purchasing an additional 74 shares in the last quarter. Bank of New Hampshire bought a new position in Agilent Technologies in the first quarter worth $38,000. Penserra Capital Management LLC bought a new position in Agilent Technologies in the first quarter worth $60,000. Finally, CVA Family Office LLC raised its holdings in Agilent Technologies by 133.3% in the first quarter. CVA Family Office LLC now owns 595 shares of the medical research company’s stock worth $79,000 after purchasing an additional 340 shares in the last quarter.
Wall Street Analyst Weigh In
A number of equities analysts have issued reports on the company. Wells Fargo & Company increased their price objective on Agilent Technologies from $130.00 to $135.00 and gave the stock an “equal weight” rating in a report on Wednesday, August 17th. Cowen increased their price objective on Agilent Technologies to $160.00 in a report on Monday, August 22nd. The Goldman Sachs Group cut their target price on Agilent Technologies from $170.00 to $140.00 and set a “buy” rating on the stock in a research note on Thursday, July 14th. Citigroup increased their target price on Agilent Technologies from $140.00 to $145.00 and gave the stock a “neutral” rating in a research note on Wednesday, August 17th. Finally, Evercore ISI increased their target price on Agilent Technologies to $145.00 in a research note on Monday, August 22nd. Four investment analysts have rated the stock with a hold rating, nine have given a buy rating and one has issued a strong buy rating to the stock. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $151.31.
Insider Transactions at Agilent Technologies
Agilent Technologies Trading Up 0.6 %
Agilent Technologies stock opened at $130.72 on Tuesday. The company has a debt-to-equity ratio of 0.54, a current ratio of 1.94 and a quick ratio of 1.41. Agilent Technologies, Inc. has a one year low of $112.52 and a one year high of $174.35. The stock has a market capitalization of $38.70 billion, a PE ratio of 29.78, a price-to-earnings-growth ratio of 2.56 and a beta of 1.06. The business’s fifty day moving average is $129.92 and its 200 day moving average is $127.04.
Agilent Technologies (NYSE:A – Get Rating) last announced its earnings results on Tuesday, August 16th. The medical research company reported $1.34 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.20 by $0.14. The business had revenue of $1.72 billion for the quarter, compared to analysts’ expectations of $1.64 billion. Agilent Technologies had a return on equity of 28.46% and a net margin of 19.94%. The business’s revenue for the quarter was up 8.3% on a year-over-year basis. During the same period last year, the firm posted $1.10 earnings per share. On average, sell-side analysts predict that Agilent Technologies, Inc. will post 5.07 EPS for the current year.
About Agilent Technologies
Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; vacuum pumps, and measurement technologies.
- Get a free copy of the StockNews.com research report on Agilent Technologies (A)
- Oracle’s Short-Term Pain Could Be Your Long-Term Gain
- Lucid is Looking Like a Clear EV Winner
- Still Lovin’ It: Investors Keep Visiting McDonald’s
- Did FedEx Just Deliver A Buying Opportunity?
- Autozone Shifts Back Into Rally-Mode, New Highs Are In Sight
Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with MarketBeat.com's FREE daily email newsletter.